SUMO2 and colorectal carcinoma: In this study, we have explored the role of global protein SUMOylation profiling in response to chemotherapy drug exposure and drug resistance in CRC, and demonstrated that an elevation of global SUMO2/3-modified substrate proteins plays a crucial role in 5-FU resistance acquisition.